US5266480A
(en)
*
|
1986-04-18 |
1993-11-30 |
Advanced Tissue Sciences, Inc. |
Three-dimensional skin culture system
|
CA1310924C
(en)
*
|
1986-04-24 |
1992-12-01 |
Francis P. Mccormick |
Infective drug delivery system
|
US5219740A
(en)
*
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
ES2094720T3
(es)
*
|
1987-05-01 |
1997-02-01 |
Gen Hospital Corp |
Implantacion transcariotica.
|
US6048729A
(en)
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
DE3852823T2
(de)
*
|
1987-09-11 |
1995-05-24 |
Whitehead Biomedical Inst |
Transduktionsveränderte fibroblasten und ihre anwendung.
|
EP0391960B1
(de)
*
|
1987-12-11 |
1994-08-17 |
Whitehead Institute For Biomedical Research |
Genetische modifizierung von endothelialen zellen
|
US6544771B1
(en)
|
1987-12-11 |
2003-04-08 |
Cell Genesys, Inc. |
Retroviral gene therapy vectors and therapeutic methods based thereon
|
US6140111A
(en)
*
|
1987-12-11 |
2000-10-31 |
Whitehead Institute For Biomedical Research |
Retroviral gene therapy vectors and therapeutic methods based thereon
|
US5580776A
(en)
*
|
1988-02-05 |
1996-12-03 |
Howard Hughes Medical Institute |
Modified hepatocytes and uses therefor
|
ATE152169T1
(de)
|
1988-02-05 |
1997-05-15 |
Whitehead Biomedical Inst |
Modifizierte hepatozyten und deren anwendung
|
US6133029A
(en)
*
|
1988-03-21 |
2000-10-17 |
Chiron Corporation |
Replication defective viral vectors for infecting human cells
|
US5716826A
(en)
*
|
1988-03-21 |
1998-02-10 |
Chiron Viagene, Inc. |
Recombinant retroviruses
|
ZA892518B
(en)
*
|
1988-04-08 |
1989-12-27 |
Intracel Corp |
Method for the in-vivo production and testing of proteins by recombinant gene expression in selected host-cells
|
US6645942B1
(en)
|
1988-04-28 |
2003-11-11 |
The Salk Institute For Biological Studies |
Somatic cell gene therapy
|
JPH04501054A
(ja)
*
|
1988-08-04 |
1992-02-27 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
所望の形質を持つ移植用培養上皮細胞
|
DE69033975T2
(de)
*
|
1989-01-23 |
2002-10-02 |
Chiron Corp |
Rekombinanttherapien für Infektionen und hyperproliferative Störungen
|
US5605821A
(en)
*
|
1989-03-08 |
1997-02-25 |
Board Of Regents Of The University Of Oklahoma |
Expression control sequences of the P-selectin gene
|
US5624824A
(en)
*
|
1989-03-24 |
1997-04-29 |
Yale University |
Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
US5091173A
(en)
*
|
1989-06-29 |
1992-02-25 |
The University Of Dundee |
Hair growth composition
|
US5817075A
(en)
*
|
1989-08-14 |
1998-10-06 |
Photogenesis, Inc. |
Method for preparation and transplantation of planar implants and surgical instrument therefor
|
SG49267A1
(en)
|
1989-08-14 |
1998-05-18 |
Photogenesis Inc |
Surgical instrument and cell isolation and transplantation
|
CA2065230C
(en)
*
|
1989-08-14 |
1999-07-20 |
Stephen E. Hughes |
Surgical instrument and cell isolation and transplantation
|
US6514238B1
(en)
*
|
1989-08-14 |
2003-02-04 |
Photogenesis, Inc. |
Method for preparation and transplantation of volute grafts and surgical instrument therefor
|
US5543399A
(en)
*
|
1989-08-22 |
1996-08-06 |
Hsc Research & Development Limited Partnership |
Cystic fibrosis transmembrane conductance regulator (CFTR) protein
|
US6984487B1
(en)
|
1989-08-22 |
2006-01-10 |
Hsc Research Development Corporation |
Cystic fibrosis gene
|
US5240846A
(en)
*
|
1989-08-22 |
1993-08-31 |
The Regents Of The University Of Michigan |
Gene therapy vector for cystic fibrosis
|
US5585362A
(en)
*
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
US6063913A
(en)
*
|
1989-08-22 |
2000-05-16 |
Hsc Research And Development Limited Partnership |
Stable heterologous propagation CFTR protein variant cDNA
|
US5863770A
(en)
*
|
1989-08-22 |
1999-01-26 |
Hsc Research And Development Limited Partnership |
Stable meterologous propagation of CFTR protein variant cDNA
|
ATE199398T1
(de)
*
|
1989-10-24 |
2001-03-15 |
Chiron Corp |
Sekretion vom mit gamma-interferon signalpeptid gebundenen humänen protein
|
US5697901A
(en)
*
|
1989-12-14 |
1997-12-16 |
Elof Eriksson |
Gene delivery by microneedle injection
|
US5661132A
(en)
*
|
1989-12-14 |
1997-08-26 |
Auragen, Inc. |
Wound healing
|
US5423778A
(en)
*
|
1989-12-14 |
1995-06-13 |
Elof Eriksson |
System and method for transplantation of cells
|
US6090790A
(en)
*
|
1989-12-14 |
2000-07-18 |
Eriksson; Elof |
Gene delivery by microneedle injection
|
DE69132616T2
(de)
*
|
1990-01-12 |
2002-02-21 |
Hsc Res Dev Corp |
Introns und exons des gens für cystische fibrose sowie mutationen an mehreren stellen des gens
|
US5068315A
(en)
*
|
1990-04-12 |
1991-11-26 |
University Of Dundee |
Composition for the regulation of hair growth
|
CA2080464A1
(en)
*
|
1990-04-17 |
1991-10-18 |
David L. Berliner |
Methods of tissue implantation
|
US5817491A
(en)
*
|
1990-09-21 |
1998-10-06 |
The Regents Of The University Of California |
VSV G pseusdotyped retroviral vectors
|
US6027722A
(en)
*
|
1990-10-25 |
2000-02-22 |
Nature Technology Corporation |
Vectors for gene transfer
|
WO1992007950A1
(en)
*
|
1990-10-25 |
1992-05-14 |
Clague Pitman Hodgson |
Method of gene transfer using retrotransposons
|
US5849686A
(en)
*
|
1991-03-11 |
1998-12-15 |
Creative Biomolecules, Inc. |
Morphogen-induced liver regeneration
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
NZ245015A
(en)
*
|
1991-11-05 |
1995-12-21 |
Transkaryotic Therapies Inc |
Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US5641670A
(en)
*
|
1991-11-05 |
1997-06-24 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US6270989B1
(en)
|
1991-11-05 |
2001-08-07 |
Transkaryotic Therapies, Inc. |
Protein production and delivery
|
US5968502A
(en)
*
|
1991-11-05 |
1999-10-19 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US6297048B1
(en)
|
1992-02-04 |
2001-10-02 |
Chiron Corporation |
Hepatitis therapeutics
|
US6045791A
(en)
*
|
1992-03-06 |
2000-04-04 |
Photogenesis, Inc. |
Retinal pigment epithelium transplantation
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
JP3973050B2
(ja)
|
1992-09-16 |
2007-09-05 |
キュリス,インコーポレイテッド |
モルフォゲン誘発性肝再生
|
US5807884A
(en)
*
|
1992-10-30 |
1998-09-15 |
Emory University |
Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
|
US5380747A
(en)
*
|
1992-10-30 |
1995-01-10 |
Emory University |
Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
|
JPH08507687A
(ja)
|
1993-03-12 |
1996-08-20 |
クレイトン ユニバーシティ |
遺伝子治療用の改良されたベクター
|
AU6829994A
(en)
*
|
1993-05-10 |
1994-12-12 |
Regents Of The University Of Michigan, The |
Gene transfer into pancreatic and biliary epithelial cells
|
US5591625A
(en)
*
|
1993-11-24 |
1997-01-07 |
Case Western Reserve University |
Transduced mesenchymal stem cells
|
US5869248A
(en)
*
|
1994-03-07 |
1999-02-09 |
Yale University |
Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
|
US5498537A
(en)
*
|
1994-03-09 |
1996-03-12 |
Cellco, Inc. |
Serum-free production of packaged viral vector
|
IL113052A0
(en)
|
1994-03-23 |
1995-06-29 |
Rhone Poulenc Rorer Sa |
Recombinant viruses, their preparation and their use in gene therapy
|
US5850002A
(en)
*
|
1994-04-20 |
1998-12-15 |
Washington University |
Animal models for loss and gain of Hox11 function
|
US6150137A
(en)
|
1994-05-27 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Immunosuppressant target proteins
|
US5888814A
(en)
*
|
1994-06-06 |
1999-03-30 |
Chiron Corporation |
Recombinant host cells encoding TNF proteins
|
US5962322A
(en)
*
|
1996-11-15 |
1999-10-05 |
Massachusetts Institute Of Technology |
Methods for modulation of cholesterol transport
|
US7078511B1
(en)
|
1994-06-23 |
2006-07-18 |
Massachusette Institute Of Technology |
Class BI and CI scavenger receptors
|
US5695993A
(en)
*
|
1994-08-12 |
1997-12-09 |
Oklahoma Medical Research Foundation |
Cloning and regulation of an endothelial cell protein C/activated protein C receptor
|
US5898066A
(en)
*
|
1994-08-26 |
1999-04-27 |
Children's Medical Center Corporation |
Trophic factors for central nervous system regeneration
|
US6057153A
(en)
*
|
1995-01-13 |
2000-05-02 |
Yale University |
Stabilized external guide sequences
|
US5683873A
(en)
*
|
1995-01-13 |
1997-11-04 |
Innovir Laboratories, Inc. |
EGS-mediated inactivation of target RNA
|
US5868728A
(en)
*
|
1995-02-28 |
1999-02-09 |
Photogenesis, Inc. |
Medical linear actuator for surgical delivery, manipulation, and extraction
|
US7422574B2
(en)
|
1995-05-19 |
2008-09-09 |
Applied Tissue Technologies, Llc |
Microseeding device for gene delivery by microneedle injection
|
US20030190753A1
(en)
*
|
1995-11-09 |
2003-10-09 |
Nature Technology Corporation |
Vectors for gene transfer
|
US5925333A
(en)
*
|
1995-11-15 |
1999-07-20 |
Massachusetts Institute Of Technology |
Methods for modulation of lipid uptake
|
US6689757B1
(en)
|
1996-02-12 |
2004-02-10 |
M.L. Laboratories Plc |
Methods for vaccination and vaccines therefor
|
US5877162A
(en)
*
|
1996-03-14 |
1999-03-02 |
Innovir Laboratories, Inc. |
Short external guide sequences
|
US6027721A
(en)
*
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
US5948681A
(en)
*
|
1996-08-14 |
1999-09-07 |
Children's Hospital Of Philadelphia |
Non-viral vehicles for use in gene transfer
|
US6108637A
(en)
|
1996-09-03 |
2000-08-22 |
Nielsen Media Research, Inc. |
Content display monitor
|
DE69732847T2
(de)
|
1996-11-08 |
2006-04-13 |
Oklahoma Medical Research Foundation, Oklahoma |
Endothel-spezifischer expression unter einfluss von epcr kontrollelementen
|
CA2205076A1
(en)
|
1997-05-14 |
1998-11-14 |
Jim Hu |
Episomal expression cassettes for gene therapy
|
US6635623B1
(en)
|
1997-06-13 |
2003-10-21 |
Baylor College Of Medicine |
Lipoproteins as nucleic acid vectors
|
US20050096288A1
(en)
*
|
1997-06-13 |
2005-05-05 |
Aragene, Inc. |
Lipoproteins as nucleic acid vectors
|
US6096303A
(en)
*
|
1997-07-31 |
2000-08-01 |
Medical College Of Georgia Research Institute, Inc. |
Method to enhance treatment of cystic tumors
|
WO1999011288A1
(en)
*
|
1997-09-05 |
1999-03-11 |
Massachusetts Institute Of Technology |
Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction
|
AU1628699A
(en)
*
|
1997-12-05 |
1999-06-28 |
Medical College Of Georgia Research Institute, Inc. |
High-affinity tryptophan transporter
|
WO1999033971A1
(en)
|
1997-12-31 |
1999-07-08 |
Medical College Of Georgia Research Institute, Inc. |
Oligomers that bind to ku protein
|
EP1061944B1
(de)
*
|
1998-03-13 |
2004-01-28 |
The University Of British Columbia |
Therapeutische chemokine rezeptor antagonisten
|
CA2245224A1
(en)
*
|
1998-08-14 |
2000-02-14 |
Jiang-Hong Giong |
Chemokine receptor antagonists and chemotherapeutics
|
CA2305787A1
(en)
*
|
2000-05-09 |
2001-11-09 |
The University Of British Columbia |
Cxcr4 antagonist treatment of hematopoietic cells
|
IL142094A0
(en)
*
|
1998-09-29 |
2002-03-10 |
Gamida Cell Ltd |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
DE69926007T2
(de)
|
1998-10-07 |
2005-12-29 |
Medical College Of Georgia Research Institute, Inc. |
Glukose-abhängiges, insulinotropisches peptid für die verwendung als osteotropes hormon
|
DE19956568A1
(de)
*
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
CA2327260A1
(en)
*
|
1999-03-03 |
2000-09-08 |
Biogen, Inc. |
Methods of modulating lipid metabolism and storage
|
WO2000053743A1
(en)
|
1999-03-12 |
2000-09-14 |
Gpc Biotech, Inc. |
Methods and reagents for identifying synthetic genetic elements
|
US6328762B1
(en)
*
|
1999-04-27 |
2001-12-11 |
Sulzer Biologics, Inc. |
Prosthetic grafts
|
US7396905B1
(en)
|
1999-05-21 |
2008-07-08 |
Mckeon Frank |
Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto
|
AUPQ206399A0
(en)
|
1999-08-06 |
1999-08-26 |
Imr Worldwide Pty Ltd. |
Network user measurement system and method
|
DE10100586C1
(de)
*
|
2001-01-09 |
2002-04-11 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines Ziegens
|
US6951839B1
(en)
|
1999-11-30 |
2005-10-04 |
Curis, Inc. |
Methods and compositions for regulating lymphocyte activity
|
US8168178B2
(en)
*
|
1999-11-30 |
2012-05-01 |
Curis, Inc. |
Methods and compositions for regulating lymphocyte activity
|
ATE361934T1
(de)
|
1999-12-30 |
2007-06-15 |
Harvard College |
Verfahren zur modulierung der aktivität von th2- zellen durch modulierung der aktivität von xbp-1
|
US6506600B2
(en)
*
|
2000-03-22 |
2003-01-14 |
University Of Arkansas |
Secreting products from skin by adeno-associated virus (AAV) gene transfer
|
US7368425B2
(en)
*
|
2006-03-24 |
2008-05-06 |
Chemokine Therapeutics Corp. |
Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
|
US7378098B2
(en)
*
|
2000-04-12 |
2008-05-27 |
The University Of British Columbia |
CXC chemokine receptor 4 agonist peptides
|
CA2335109A1
(en)
*
|
2000-04-12 |
2001-10-12 |
Chemokine Therapeutics Corporation |
Cxcr4 agonist treatment of hematopoietic cells
|
US20050059584A1
(en)
*
|
2002-08-16 |
2005-03-17 |
Ahmed Merzouk |
Novel chemokine mimetics synthesis and their use
|
EP1702983A3
(de)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Gewebespezifische und pathogenspezifische giftige Verbindungen, Ribozyme, DNAzyme und Antisenseolinukleotide sowie Anwendungen dafür
|
DE60139394D1
(de)
|
2000-04-28 |
2009-09-10 |
Asklepios Biopharmaceutical In |
Für das dystrophin-minigen kodierende dna-sequenzen und verfahren zu deren verwendung
|
EP1350106A2
(de)
*
|
2000-08-11 |
2003-10-08 |
Agilix Corporation |
Hochempfindliches nachweissystem
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
EP1326892A2
(de)
|
2000-10-12 |
2003-07-16 |
University of Rochester |
Zusammensetzungen die die proliferation von krebszellen hemmen
|
US7767802B2
(en)
|
2001-01-09 |
2010-08-03 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of anti-apoptotic genes
|
US7423142B2
(en)
*
|
2001-01-09 |
2008-09-09 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of anti-apoptotic genes
|
ES2328796T3
(es)
|
2001-03-14 |
2009-11-18 |
Myriad Genetics, Inc. |
Interaccion tsg101-gag y uso de la misma.
|
US20040245317A1
(en)
*
|
2001-04-06 |
2004-12-09 |
Vladimir Larionov |
Artificial chromosomes that can shuttle between bacteria yeast and mammalian cells
|
US7262174B2
(en)
*
|
2001-05-09 |
2007-08-28 |
Geron Corporation |
Treatment for wounds
|
EP1404713A4
(de)
*
|
2001-05-24 |
2004-09-22 |
Human Dna Technology Inc |
Neues keratinocyte growth factor 2 analogon in haarfollikeln
|
US20070015144A9
(en)
*
|
2001-05-25 |
2007-01-18 |
Genset, S.A. |
Human cDNAs and proteins and uses thereof
|
CA2448253A1
(en)
*
|
2001-05-25 |
2002-11-28 |
Genset S.A. |
Human cdnas and proteins and uses thereof
|
US20030095952A1
(en)
*
|
2001-06-13 |
2003-05-22 |
Krause Diane S. |
Multi-organ engraftment with a single bone marrow-derived stem cell
|
ES2184623B1
(es)
*
|
2001-06-29 |
2004-09-16 |
Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas (C.I.E.M.A.T.) |
Piel artificial autologa secretora de leptina y metodo de obtencion.
|
EP1900815B1
(de)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
In-vivo-Herstellung kleiner interferierender und Genverstummung vermittelnder RNAs
|
CA2453183C
(en)
|
2001-07-12 |
2016-05-10 |
University Of Massachusetts |
In vivo production of small interfering rnas that mediate gene silencing
|
CA2456716A1
(en)
|
2001-08-09 |
2003-02-27 |
Sebastiano Andreana |
Tissue implants and methods for making and using same
|
AU2002361471A1
(en)
*
|
2001-08-30 |
2003-03-18 |
Mount Sinai School Of Medicine Of New York University |
Alternatively spliced circulating tissue factor
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
KR20040081418A
(ko)
*
|
2001-09-28 |
2004-09-21 |
에스페리온 테라피유틱스 인코포레이티드 |
약물의 국소투여를 통한 재협착의 예방 및 치료
|
EP1438413A4
(de)
*
|
2001-10-03 |
2006-06-07 |
Selective Genetics Inc |
Einen flüssigkeitsraum durchquerende nukleinsäuremoleküle und expression in reparaturzellen
|
WO2003029430A2
(en)
*
|
2001-10-04 |
2003-04-10 |
The Government Of The United States Of America, As |
Tandem repeat markers
|
US7745418B2
(en)
*
|
2001-10-12 |
2010-06-29 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting viral replication
|
CA2466861A1
(en)
*
|
2001-11-06 |
2003-07-10 |
Agilix Corporation |
Sensitive coded detection systems
|
US7255874B1
(en)
|
2001-12-21 |
2007-08-14 |
Closure Medical Corporation |
Biocompatible polymers and adhesives: compositions, methods of making and uses related thereto
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
EP1465982A4
(de)
|
2002-01-25 |
2006-06-07 |
Gamida Cell Ltd |
Verfahren zur expansion von stamm- und vorläuferzellen und damit erhaltene expandierte zellpopulationen
|
US6939554B2
(en)
*
|
2002-02-05 |
2005-09-06 |
Michigan Biotechnology Institute |
Antimicrobial polymer
|
AU2003213075A1
(en)
*
|
2002-02-14 |
2003-09-04 |
Henry J. Kaplan |
Subretinal implantation device and surgical cannulas for use therewith
|
AU2003222030A1
(en)
*
|
2002-03-18 |
2003-10-08 |
The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Health |
Regulation of ins(3456)p4 signalling by a reversible kinase/phosphatase and methods and compositions related thereto
|
EP1490085A2
(de)
*
|
2002-03-25 |
2004-12-29 |
Uab Research Foundation |
Rezeptor-homolog, reagenzien und derer verwendungen
|
CA2485989A1
(en)
*
|
2002-05-17 |
2003-11-27 |
Esperion Therapeutics, Inc. |
Methods and compositions for the treatment of ischemic reperfusion
|
US6943021B2
(en)
*
|
2002-06-07 |
2005-09-13 |
Mattek Corporation |
Three dimensional vaginal tissue model containing immune cells
|
US7208467B2
(en)
|
2002-06-07 |
2007-04-24 |
Monty Krieger |
Lipid-altering compositions for the treatment of infertility
|
US8271778B1
(en)
|
2002-07-24 |
2012-09-18 |
The Nielsen Company (Us), Llc |
System and method for monitoring secure data on a network
|
CA2421269A1
(en)
|
2002-08-09 |
2004-02-09 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
EP1546170A4
(de)
*
|
2002-09-20 |
2007-08-29 |
Univ Yale |
Riboswitche, verfahren zu deren anwendung und zusammensetzungen, die mit riboswitchen verwendet werden
|
JP2006503110A
(ja)
*
|
2002-10-09 |
2006-01-26 |
トーラーレックス, インク. |
エフェクタt細胞または制御性t細胞に選択的に結合する分子およびその使用方法
|
US8658377B2
(en)
|
2002-11-15 |
2014-02-25 |
Morehouse School Of Medicine |
Detecting cancer with anti-CCL25 and anti-CCR9 antibodies
|
US9233120B2
(en)
|
2002-11-15 |
2016-01-12 |
Jyant Technologies |
Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration
|
US8512701B2
(en)
|
2002-11-15 |
2013-08-20 |
Morehouse School Of Medicine |
Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration
|
WO2004045520A2
(en)
|
2002-11-15 |
2004-06-03 |
Musc Foundation For Research Development |
Complement receptor 2 targeted complement modulators
|
EP2258724A1
(de)
|
2002-11-21 |
2010-12-08 |
Celltech R & D, Inc. |
Modulierung von Immunantworten mittels multimeriserter Anti-CD83 Antikörper
|
US9388427B2
(en)
*
|
2002-12-02 |
2016-07-12 |
Biovec, Llc |
In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
|
US7803365B2
(en)
*
|
2002-12-02 |
2010-09-28 |
Biovec, Llc |
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
|
WO2004064785A2
(en)
|
2003-01-14 |
2004-08-05 |
Dana Farber Cancer Institute |
Cancer therapy sensitizer
|
DE10302421A1
(de)
*
|
2003-01-21 |
2004-07-29 |
Ribopharma Ag |
Doppelsträngige Ribonukleinsäure mit verbesserter Wirksamkeit
|
US20050106124A1
(en)
*
|
2003-02-25 |
2005-05-19 |
Sehgal Lakshman R. |
Therapeutic applications of thrombomodulin gene via viral and non-viral vectors
|
US20050186289A1
(en)
*
|
2003-04-01 |
2005-08-25 |
Medical College Of Georgia Research Institute, Inc. |
Regulation of T cell-mediated immunity by D isomers of inhibitors of indoleamine-2,3-dioxygenase
|
US7598287B2
(en)
|
2003-04-01 |
2009-10-06 |
Medical College Of Georgia Research Institute, Inc. |
Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
|
WO2004101072A1
(en)
|
2003-05-16 |
2004-11-25 |
Universite Laval |
Cns chloride modulation and uses thereof
|
DE602004029678D1
(de)
|
2003-06-02 |
2010-12-02 |
Univ Massachusetts |
Verfahren und zusammensetzungen zur verbesserung der wirksamkeit und spezifität von fnai
|
AU2004248136B2
(en)
|
2003-06-02 |
2011-09-15 |
University Of Massachusetts |
Methods and compositions for controlling efficacy of RNA silencing
|
DK1636260T3
(da)
|
2003-06-10 |
2009-06-22 |
Biogen Idec Inc |
Forbedret udskillelse af Neublastin
|
EP1677735B1
(de)
|
2003-10-17 |
2014-07-23 |
Joslin Diabetes Center, Inc. |
Verfahren und zusammensetzungen zur modulierung der adipozyten-funktion
|
RU2006117304A
(ru)
|
2003-10-20 |
2007-12-10 |
Нсджин А/С (Dk) |
Генная терапия болезни паркинсона iv vivo
|
EP1918000A2
(de)
|
2003-11-05 |
2008-05-07 |
Schering Corporation |
Verbindungen aus lipidverändernden Wirkstoffen und substituierten Azetidinonen und Behandlungen für Gefäßzustände
|
US7670771B2
(en)
|
2004-01-21 |
2010-03-02 |
University Of Utah Research Foundation |
Mutant sodium channel Nav1.7 nucleic acid methods
|
US20050272678A1
(en)
*
|
2004-02-11 |
2005-12-08 |
Bodine Peter Van N |
BMP-6 estrogen responsive element and methods of use thereof
|
US20080020376A1
(en)
*
|
2004-03-10 |
2008-01-24 |
Akopian Armen N |
Enriched Cdna Expression Libraries and Methods of Making and Using Same
|
EP1735009A4
(de)
|
2004-03-12 |
2011-03-30 |
Alnylam Pharmaceuticals Inc |
Irna mittel targeting vegf
|
JP5010464B2
(ja)
|
2004-03-30 |
2012-08-29 |
エヌエスジーン・アクティーゼルスカブ |
成長因子、NsG33の治療上の使用
|
WO2005097206A2
(en)
*
|
2004-04-06 |
2005-10-20 |
Cedars-Sinai Medical Center |
Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein a-i and apolipoprotein a-i milano
|
AU2005326817B2
(en)
|
2004-05-21 |
2012-04-19 |
Benaroya Research Institute |
Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
|
US20060021075A1
(en)
*
|
2004-07-15 |
2006-01-26 |
Chyung-Ru Wang |
Group 1 CD1 transgenic mice and their uses
|
US20090136552A1
(en)
*
|
2004-07-30 |
2009-05-28 |
Mette Gronborg |
Growth factors nsg28, nsg30, and nsg32
|
CA2576193A1
(en)
|
2004-08-03 |
2006-02-16 |
Biogen Idec Ma Inc. |
Taj in neuronal function
|
US20060063187A1
(en)
*
|
2004-09-15 |
2006-03-23 |
Hotamisligil Gokhan S |
Modulation of XBP-1 activity for treatment of metabolic disorders
|
WO2006030442A2
(en)
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
US20080131433A1
(en)
*
|
2004-09-27 |
2008-06-05 |
The Uab Research Foundation |
Fc Receptor Homolog Antibodies And Uses Thereof
|
WO2006069181A2
(en)
|
2004-12-21 |
2006-06-29 |
Musc Foundation For Research Development |
Compositions and methods for promoting wound healing and tissue regeneration
|
US20070207555A1
(en)
*
|
2005-02-03 |
2007-09-06 |
Cesar Guerra |
Ultra-sensitive detection systems using multidimension signals
|
CA2597945C
(en)
|
2005-02-17 |
2016-07-12 |
Biogen Idec Ma Inc. |
Treating neurological disorders
|
AU2006302245A1
(en)
*
|
2005-10-06 |
2007-04-19 |
Emthrax, Llc |
Methods and compositions relating to anthrax spore glycoproteins as vaccines
|
WO2007047512A2
(en)
|
2005-10-14 |
2007-04-26 |
Musc Foundation For Research Development |
Inhibition of pax2 by defb1 induction as a therapy for cancer
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
EP1942948A4
(de)
*
|
2005-11-04 |
2010-03-03 |
Alnylam Pharmaceuticals Inc |
Zusammensetzungen und verfahren zur hemmung der expression des nav1.8-genes
|
ATE510545T1
(de)
|
2005-11-09 |
2011-06-15 |
Alnylam Pharmaceuticals Inc |
Zusammensetzungen und verfahren zur hemmung der expression von faktor v leiden mutationsgen
|
EP1948798B1
(de)
|
2005-11-18 |
2015-04-01 |
Glenmark Pharmaceuticals S.A. |
Anti-alpha2-integrin-antikörper und deren verwendungen
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
US8313901B2
(en)
*
|
2005-12-21 |
2012-11-20 |
Yale University |
Methods and compositions related to the modulation of riboswitches
|
CA2636469A1
(en)
|
2006-01-05 |
2007-07-19 |
University Of Utah Research Foundation |
Methods and compositions related to improving properties of pharmacological agents targeting nervous system
|
US8470965B2
(en)
*
|
2006-03-01 |
2013-06-25 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
WO2007103739A2
(en)
*
|
2006-03-01 |
2007-09-13 |
The University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
KR20170061189A
(ko)
|
2006-03-31 |
2017-06-02 |
알닐람 파마슈티칼스 인코포레이티드 |
Eg5 유전자의 발현을 억제하는 이본쇄 리보핵산
|
EP2013222B1
(de)
*
|
2006-04-28 |
2013-02-13 |
Alnylam Pharmaceuticals Inc. |
Zusammensetzungen und verfahren zur hemmung der expression eines gens aus dem jc-virus
|
NZ587616A
(en)
|
2006-05-11 |
2012-03-30 |
Alnylam Pharmaceuticals Inc |
Compositions and methods for inhibiting expression of the pcsk9 gene
|
CN101489566B
(zh)
|
2006-05-19 |
2012-04-18 |
阿尔尼拉姆医药品有限公司 |
Aha基因的RNAi调控及其治疗性应用
|
CA2653451C
(en)
*
|
2006-05-22 |
2015-12-29 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of ikk-b gene
|
ES2685802T3
(es)
|
2006-05-25 |
2018-10-11 |
Biogen Ma Inc. |
Antagonista de VLA-1 para su utilización en el tratamiento de un accidente cerebrovascular
|
US8598333B2
(en)
*
|
2006-05-26 |
2013-12-03 |
Alnylam Pharmaceuticals, Inc. |
SiRNA silencing of genes expressed in cancer
|
US20100159450A1
(en)
|
2006-06-23 |
2010-06-24 |
Susanne Wagner |
Dpyd gene variants and use thereof
|
WO2008033866A2
(en)
*
|
2006-09-11 |
2008-03-20 |
Yale University |
Methods and compositions for the use of lysine riboswitches
|
US20100190689A1
(en)
|
2006-09-21 |
2010-07-29 |
University Of Rochester |
Compositions and methods related to protein displacement therapy for myotonic distrophy
|
EP2104509A4
(de)
|
2006-12-11 |
2010-03-24 |
Univ Utah Res Found |
Zusammensetzungen und verfahren zur behandlung von pathologischer angiogenese und gefässpermeabilität
|
US20120030779A1
(en)
|
2007-01-18 |
2012-02-02 |
University Of Utah Research Foundtion |
Compositions and methods for detecting, treating, or preventing reductive stress
|
EP2111553B1
(de)
|
2007-01-24 |
2018-09-19 |
Carnegie Mellon University |
Optische biosensoren
|
US8097588B2
(en)
*
|
2007-02-08 |
2012-01-17 |
Sanford-Burnham Medical Research Institute |
Trophinin-binding peptides and uses thereof
|
AU2008227458A1
(en)
|
2007-03-22 |
2008-09-25 |
Yale University |
Methods and compositions related to riboswitches that control alternative splicing
|
PE20090064A1
(es)
|
2007-03-26 |
2009-03-02 |
Novartis Ag |
Acido ribonucleico de doble cadena para inhibir la expresion del gen e6ap humano y composicion farmaceutica que lo comprende
|
US8053553B2
(en)
|
2007-05-09 |
2011-11-08 |
Socpra Sciences Sante Et Humaines |
Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
|
AU2008260089A1
(en)
*
|
2007-05-29 |
2008-12-11 |
Yale University |
Methods and compositions related to riboswitches that control alternative splicing and RNA processing
|
EP2426218A1
(de)
|
2007-05-29 |
2012-03-07 |
Yale University |
Riboswitches sowie Verfahren und Zusammensetzungen zur Verwendung von und mit Riboswitches
|
EP2316943B1
(de)
|
2007-07-05 |
2013-06-19 |
Novartis AG |
DSRNA zur Behandlung viraler Infektionen
|
AU2008296487A1
(en)
|
2007-08-28 |
2009-03-12 |
The Uab Research Foundation |
Synthetic apolipoprotein E mimicking polypeptides and methods of use
|
US9422363B2
(en)
|
2007-08-28 |
2016-08-23 |
Uab Research Foundation |
Synthetic apolipoprotein E mimicking polypeptides and methods of use
|
WO2009039442A1
(en)
|
2007-09-21 |
2009-03-26 |
California Institute Of Technology |
Nfia in glial fate determination, glioma therapy and astrocytoma treatment
|
DK2222697T3
(da)
|
2007-11-01 |
2013-03-11 |
Perseid Therapeutics Llc |
Immunsuppressive polypeptider og nukleinsyrer
|
US8501912B2
(en)
*
|
2007-12-03 |
2013-08-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Filipil compositions and methods for treating cancer
|
EP2617828B1
(de)
|
2007-12-10 |
2014-09-24 |
Alnylam Pharmaceuticals Inc. |
Zusammensetzungen und Verfahren zur Hemmung der Faktor VII-Genexpression
|
KR101397407B1
(ko)
|
2008-03-05 |
2014-06-19 |
알닐람 파마슈티칼스 인코포레이티드 |
Eg5 및 VEGF 유전자의 발현을 억제하기 위한 조성물 및 방법
|
US20090233993A1
(en)
*
|
2008-03-06 |
2009-09-17 |
Burnham Institute For Medical Research |
Compositions and methods for inhibiting gsk3 activity and uses thereof
|
AU2009244308A1
(en)
|
2008-05-06 |
2009-11-12 |
Joslin Diabetes Center, Inc. |
Methods and compositions for inducing brown adipogenesis
|
US8946291B2
(en)
|
2008-08-15 |
2015-02-03 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Compositions and methods for treating pigmentary conditions and melanoma
|
EP2331690B1
(de)
|
2008-09-02 |
2016-01-13 |
Alnylam Pharmaceuticals Inc. |
Zusammensetzungen und verfahren zur hemmung der expression eines mutierten egfr-gens
|
EP3109321B1
(de)
|
2008-09-25 |
2019-05-01 |
Alnylam Pharmaceuticals, Inc. |
Zusammensetzungen aus lipidformulierungen und verfahren zur hemmung der serum-amyloid-a-genexpression
|
IL281434B2
(en)
|
2008-10-20 |
2023-09-01 |
Alnylam Pharmaceuticals Inc |
Compounds and methods for inhibiting transthyretin expression
|
EP2894166A1
(de)
|
2008-11-10 |
2015-07-15 |
Alexion Pharmaceuticals, Inc. |
Verfahren und Zusammensetzungen zur Behandlung von komplementassoziierten Störungen
|
US20120070443A1
(en)
|
2008-12-02 |
2012-03-22 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
CA2746514C
(en)
|
2008-12-10 |
2018-11-27 |
Alnylam Pharmaceuticals, Inc. |
Gnaq targeted dsrna compositions and methods for inhibiting expression
|
US20120021039A1
(en)
|
2009-01-23 |
2012-01-26 |
Nsgene A/S |
Expression of neuropeptides in mammalian cells
|
CA2753438A1
(en)
|
2009-02-24 |
2010-09-02 |
Alexion Pharmaceuticals, Inc. |
Antibodies containing therapeutic tpo/epo mimetic peptides
|
US20120041051A1
(en)
|
2009-02-26 |
2012-02-16 |
Kevin Fitzgerald |
Compositions And Methods For Inhibiting Expression Of MIG-12 Gene
|
AU2010223967B2
(en)
|
2009-03-12 |
2015-07-30 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
|
EP2408904B1
(de)
|
2009-03-20 |
2017-10-18 |
Mesoblast, Inc. |
Herstellung von umprogrammierten pluripotenten zellen
|
WO2010132665A1
(en)
|
2009-05-15 |
2010-11-18 |
Yale University |
Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
|
US9149024B2
(en)
|
2009-06-22 |
2015-10-06 |
Massachusetts Eye & Ear Infirmary |
Islet1 (Isl1) and hearing loss
|
EP3064595B1
(de)
|
2009-10-21 |
2019-02-27 |
Agios Pharmaceuticals, Inc. |
Verfahren für zellproliferationsbedingte erkrankungen
|
CN102695526A
(zh)
|
2009-11-09 |
2012-09-26 |
吉恩波多治疗股份公司 |
用于神经元特异性的体内连续dopa合成的新型病毒载体构建体
|
EP2524042A2
(de)
|
2010-01-12 |
2012-11-21 |
Yale University |
Strukturierte rna-motive sowie verbindungen und verfahren zu ihrer verwendung
|
EP2524054A2
(de)
|
2010-01-14 |
2012-11-21 |
Haplomics, Inc. |
Vorhersage und reduktion der alloimmunogenität von proteintherapeutika
|
WO2011088163A1
(en)
|
2010-01-14 |
2011-07-21 |
President And Fellows Of Harvard College |
Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination
|
EP3329924B1
(de)
|
2010-03-29 |
2021-05-05 |
Alnylam Pharmaceuticals, Inc. |
Dsrna-therapie für durch transthyretin (ttr) vermittelte augenamyloidose
|
ES2552954T3
(es)
|
2010-04-30 |
2015-12-03 |
Alexion Pharmaceuticals, Inc. |
Anticuerpos anti-C5a y métodos para el uso de los anticuerpos
|
CA2813013C
(en)
|
2010-10-01 |
2019-10-22 |
Nsgene A/S |
Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
|
WO2012051301A1
(en)
|
2010-10-12 |
2012-04-19 |
President And Fellows Of Harvard College |
Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism
|
US8815942B2
(en)
|
2010-10-20 |
2014-08-26 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
|
JP2014505239A
(ja)
|
2010-12-14 |
2014-02-27 |
モアハウス スクール オブ メディスン |
癌の治療または検出のための抗cxcl13および抗cxcr5抗体の使用
|
CA2858811A1
(en)
|
2010-12-15 |
2012-06-12 |
Neuroadjuvants, Inc. |
Neuropeptide analogs, compositions, and methods for treating pain
|
EP3026432A3
(de)
|
2010-12-27 |
2016-07-27 |
Brown University |
Verfahren zur vorhersage der patientenreaktion auf eine behandlung mit biglycan
|
US10130687B2
(en)
|
2011-01-05 |
2018-11-20 |
Rhode Island Hospital |
Compositions and methods for the treatment of orthopedic disease or injury
|
WO2012109238A2
(en)
|
2011-02-07 |
2012-08-16 |
President And Fellows Of Harvard College |
Methods for increasing immune responses using agents that directly bind to and activate ire-1
|
EP2717909B1
(de)
|
2011-06-04 |
2017-12-06 |
Rochester General Hospital Research Institute |
Zusammensetzungen und verfahren in zusammenhang mit p6 von haemophilus influenzae
|
WO2012177949A2
(en)
|
2011-06-21 |
2012-12-27 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibition of expression of protein c (proc) genes
|
KR20230084331A
(ko)
|
2011-06-21 |
2023-06-12 |
알닐람 파마슈티칼스 인코포레이티드 |
아포리포단백질 c-iii(apoc3) 유전자의 발현 억제를 위한 조성물 및 방법
|
US9474786B2
(en)
|
2011-09-05 |
2016-10-25 |
Nsgene A/S |
Treatment of allodynia
|
US10047345B2
(en)
|
2012-02-13 |
2018-08-14 |
Gamida-Cell Ltd. |
Culturing of mesenchymal stem cells with FGF4 and nicotinamide
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
WO2014018851A1
(en)
|
2012-07-26 |
2014-01-30 |
Joslin Diabetes Center, Inc. |
Predicting and treating diabetic complications
|
US9856474B2
(en)
|
2013-01-16 |
2018-01-02 |
Iowa State University Research Foundation, Inc. |
Deep intronic target for splicing correction on spinal muscular atrophy gene
|
EP2851086A1
(de)
|
2013-09-20 |
2015-03-25 |
Sanofi |
Serpine: Verfahren zur therapeutischen ß-Zellen-Regeneration und Funktion
|
EP2958585A1
(de)
|
2013-02-22 |
2015-12-30 |
Sanofi |
Serpine: verfahren zur therapeutischen beta-zellen-regeneration und -funktion
|
EP2769732A1
(de)
|
2013-02-22 |
2014-08-27 |
Sanofi |
Serpine: Verfahren zur therapeutischen Beta-Zellen-Regeneration und Funktion
|
BR112015023108A8
(pt)
|
2013-03-13 |
2018-01-23 |
Geneweave Biosciences Inc |
sistema de acondicionamento de célula bacteriana, método para acondicionamento de uma molécula de ácido nucléico repórter, composição, método para detectar uma presença ou uma ausência de uma célula bacteriana em uma amostra, vetor, método para detectar um transcrito alvo em uma célula, método para detectar a presença de uma célula bacteriana em uma amostra e kit.
|
US9185435B2
(en)
|
2013-06-25 |
2015-11-10 |
The Nielsen Company (Us), Llc |
Methods and apparatus to characterize households with media meter data
|
ES2724300T3
(es)
|
2013-09-25 |
2019-09-10 |
Univ Cornell |
Compuestos para inducir inmunidad antitumoral y métodos de lo mismo
|
WO2015123201A1
(en)
|
2014-02-11 |
2015-08-20 |
The Nielsen Company (Us), Llc |
Methods and apparatus to calculate video-on-demand and dynamically inserted advertisement viewing probability
|
WO2015123561A2
(en)
|
2014-02-14 |
2015-08-20 |
University Of Utah Research Foundation |
Methods and compositions for inhibiting retinopathy of prematurity
|
NZ711451A
(en)
|
2014-03-07 |
2016-05-27 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
US10494417B2
(en)
|
2014-03-25 |
2019-12-03 |
University Of Utah Research Foundation |
Peptide inhibitors of BCR-ABL oligomerization
|
RS61307B1
(sr)
|
2014-07-24 |
2021-02-26 |
Massachusetts Eye & Ear Infirmary |
Rpgr genska terapija za pigmentnu retinopatiju
|
WO2016018665A1
(en)
|
2014-07-31 |
2016-02-04 |
Uab Research Foundation |
Apoe mimetic peptides and higher potency to clear plasma cholesterol
|
CA2973878A1
(en)
|
2015-01-22 |
2016-07-28 |
University Of Massachusetts |
Cancer immunotherapy
|
JP2018506526A
(ja)
|
2015-01-29 |
2018-03-08 |
ボード オブ トラスティーズ オブ ミシガン ステイト ユニバーシティBoard Of Trustees Of Michigan State University |
クリプティックポリペプチドおよびその使用
|
HUE051491T2
(hu)
|
2015-03-06 |
2021-03-01 |
Massachusetts Eye & Ear Infirmary |
Gén-augmentációs terápiák a PRPF31 gén mutációi által okozott öröklött retina degenerációra
|
US10219039B2
(en)
|
2015-03-09 |
2019-02-26 |
The Nielsen Company (Us), Llc |
Methods and apparatus to assign viewers to media meter data
|
EP3268025B1
(de)
|
2015-03-10 |
2020-05-06 |
University of Massachusetts |
Abzielung auf gdf6 und bmp-signalisierung für antimelanomtherapie
|
US10723794B2
(en)
|
2015-03-18 |
2020-07-28 |
University Of South Carolina |
Anti-CcL8 antibodies and uses thereof
|
EP3294334B1
(de)
|
2015-05-11 |
2020-07-08 |
The Johns Hopkins University |
Autoimmunantikörper zur verwendung bei der hemmung des wachstums von krebszellen
|
EP3294332A4
(de)
|
2015-05-14 |
2018-12-26 |
Joslin Diabetes Center, Inc. |
Retinolbindendes protein 3 (rbp3) als schutzfaktor bei nicht diabetischer netzhautdegeneration
|
JP2018522595A
(ja)
|
2015-08-03 |
2018-08-16 |
ミョドパ・リミテッド |
L−dopaの全身合成及び調節
|
US9848224B2
(en)
|
2015-08-27 |
2017-12-19 |
The Nielsen Company(Us), Llc |
Methods and apparatus to estimate demographics of a household
|
WO2017066796A2
(en)
|
2015-10-16 |
2017-04-20 |
The Children's Medical Center Corporation |
Modulators of telomere disease
|
AU2016355178B9
(en)
|
2015-11-19 |
2019-05-30 |
Massachusetts Institute Of Technology |
Lymphocyte antigen CD5-like (CD5L)-interleukin 12B (p40) heterodimers in immunity
|
US11719704B2
(en)
|
2015-12-30 |
2023-08-08 |
Momenta Pharmaceuticals, Inc. |
Methods related to biologics
|
ES2953538T3
(es)
|
2016-05-20 |
2023-11-14 |
Braingene Ab |
Dominios desestabilizadores para estabilizar condicionalmente una proteína
|
WO2018001858A1
(en)
|
2016-06-27 |
2018-01-04 |
University Of Copenhagen |
Tailored assembly of a modular bud polypeptide
|
US11459568B2
(en)
|
2016-10-31 |
2022-10-04 |
University Of Massachusetts |
Targeting microRNA-101-3p in cancer therapy
|
US10791355B2
(en)
|
2016-12-20 |
2020-09-29 |
The Nielsen Company (Us), Llc |
Methods and apparatus to determine probabilistic media viewing metrics
|
WO2018191599A1
(en)
|
2017-04-14 |
2018-10-18 |
University Of Massachusetts |
Brown fat-selective adipokines
|
MX2019015477A
(es)
|
2017-06-28 |
2020-07-28 |
Regeneron Pharma |
Proteinas de union a antigeno del virus del papiloma anti-humano (vph) y metodos de uso de las mismas.
|
PT3658184T
(pt)
|
2017-07-27 |
2023-11-29 |
Alexion Pharma Inc |
Formulações de anticorpo anti-c5 de elevada concentração
|
WO2019055618A1
(en)
|
2017-09-15 |
2019-03-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
METHODS OF CLASSIFYING RESPONSES TO ANTICANCER IMMUNOTHERAPY
|
AU2018351053A1
(en)
|
2017-10-18 |
2020-05-07 |
Washington University |
Dominant negative sarm1 molecules as a therapeutic strategy for neurodegenerative diseases or disorders
|
US11008602B2
(en)
|
2017-12-20 |
2021-05-18 |
Roche Molecular Systems, Inc. |
Non-replicative transduction particles and transduction particle-based reporter systems
|
SG11202011815SA
(en)
|
2018-06-01 |
2020-12-30 |
Sanofi Sa |
Combination therapy for treating hepatitis b virus infection
|
WO2020018825A1
(en)
|
2018-07-19 |
2020-01-23 |
Regeneron Pharmaceuticals, Inc. |
Chimeric antigen receptors with bcma specificity and uses thereof
|
AU2019364367A1
(en)
|
2018-10-23 |
2021-05-27 |
Regeneron Pharmaceuticals, Inc. |
NY-ESO-1 T cell receptors and methods of use thereof
|
WO2020120649A1
(en)
|
2018-12-13 |
2020-06-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Artificial antigen presenting cells that constitutively express an antigen along with a hla-class ii molecule
|
CN113227404A
(zh)
|
2018-12-27 |
2021-08-06 |
豪夫迈·罗氏有限公司 |
用于检测鲍氏不动杆菌的非复制型转导颗粒和基于转导颗粒的报告***
|
US11572595B2
(en)
|
2018-12-31 |
2023-02-07 |
Roche Molecular Systems, Inc. |
Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems
|
IT201900007060A1
(it)
|
2019-05-21 |
2020-11-21 |
St Superiore Di Sanita |
Cellule tumorali ingegnerizzate e loro usi
|
IT201900012540A1
(it)
|
2019-07-22 |
2021-01-22 |
Humanitas Mirasole Spa |
Inibitori di CHI3L1 e loro usi
|
BR112022001194A2
(pt)
|
2019-07-24 |
2022-06-07 |
Regeneron Pharma |
Receptores de antígeno quimérico com especificidade de mage a4 e usos dos mesmos
|
WO2021067550A1
(en)
|
2019-10-02 |
2021-04-08 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions for identifying neoantigens for use in treating and preventing cancer
|
WO2021067526A1
(en)
|
2019-10-02 |
2021-04-08 |
Alexion Pharmaceuticals, Inc. |
Complement inhibitors for treating drug-induced complement-mediated response
|
KR20220109435A
(ko)
|
2019-12-03 |
2022-08-04 |
에보텍 인터내셔널 게엠베하 |
B형 간염 감염 치료에서의 사용을 위한 인터페론-결합된 항원 결합 단백질
|
EP4069291A1
(de)
|
2019-12-03 |
2022-10-12 |
Evotec International GmbH |
Interferon-assoziierte antigenbindende proteine und verwendungen davon
|
WO2021136752A1
(en)
|
2019-12-31 |
2021-07-08 |
F. Hoffmann-La Roche Ag |
Quantitative pcr screening of inducible prophage from bacterial isolates
|
EP4093753A1
(de)
|
2020-01-24 |
2022-11-30 |
Regeneron Pharmaceuticals, Inc. |
Bevorzugt exprimierte antigene in melanomen (prame) t-zell-rezeptoren und verfahren zur verwendung davon
|
CA3176425A1
(en)
|
2020-04-24 |
2021-10-28 |
Millennium Pharmaceuticals, Inc. |
Anti-cd19 antibodies and uses thereof
|
TW202208417A
(zh)
|
2020-05-05 |
2022-03-01 |
美商再生元醫藥公司 |
用於治療癌症之組合物及方法
|
AU2021340793A1
(en)
|
2020-09-14 |
2023-05-11 |
Vor Biopharma Inc. |
Single domain antibodies against cd33
|
TW202241946A
(zh)
|
2020-12-18 |
2022-11-01 |
美商健生生物科技公司 |
針對整合素α11β1之抗體
|
WO2022137171A2
(en)
|
2020-12-24 |
2022-06-30 |
Novocure Gmbh |
Methods and compositions for using alternating electric fields in gene therapy
|
EP4320149A1
(de)
|
2021-04-09 |
2024-02-14 |
Takeda Pharmaceutical Company Limited |
Gegen komplementfaktor d gerichtete antikörper und verwendungen davon
|
IL307940A
(en)
|
2021-04-26 |
2023-12-01 |
Millennium Pharm Inc |
Anti-ADGRE2 antibodies and their uses
|
IL307939A
(en)
|
2021-04-26 |
2023-12-01 |
Millennium Pharm Inc |
Anti-CLEC12A antibodies and uses thereof
|
JP2024516308A
(ja)
|
2021-05-04 |
2024-04-12 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Mage-a4特異性を有するキメラ抗原受容体及びその使用
|
WO2022233989A1
(en)
|
2021-05-06 |
2022-11-10 |
Hoba Therapeutics Aps |
Prevention and treatment of chemotherapy-induced neuropathic pain
|
WO2022258720A1
(en)
|
2021-06-09 |
2022-12-15 |
Evotec International Gmbh |
Interferon-associated antigen binding proteins for use for the treatment or prevention of coronavirus infection
|
WO2023068382A2
(en)
|
2021-10-20 |
2023-04-27 |
Takeda Pharmaceutical Company Limited |
Compositions targeting bcma and methods of use thereof
|
WO2023104960A1
(en)
|
2021-12-10 |
2023-06-15 |
Hoba Therapeutics Aps |
Treatment of nociceptive pain
|
WO2023201238A1
(en)
|
2022-04-11 |
2023-10-19 |
Vor Biopharma Inc. |
Binding agents and methods of use thereof
|
WO2023240109A1
(en)
|
2022-06-07 |
2023-12-14 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules for modulating t-cell activity, and uses thereof
|
WO2024091669A1
(en)
|
2022-10-28 |
2024-05-02 |
Ginkgo Bioworks, Inc. |
Chimeric antigen receptors comprising an intracellular domain pair
|